Helene Hovington

Quebec, QC, Canada

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 34 publications

Cohort profile: BioCaPPE (Biomarkers of Prostate Cancer/Prevention and Environment) - a Canadian multicentre prospective study of lifestyle and candidate biomarkers in relation to prostate cancer risk.

Cohort profile: BioCaPPE (Biomarkers of Prostate Cancer/Prevention and Environment) - a Canadian multicentre prospective study of lifestyle and candidate biomarkers in relation to prostate cancer risk.

Journal: BMJ open
Published: May 28, 2026

ANGPTL3, Apo CIII, Leptin and Triglycerides Are Elevated in Metastatic Prostate Cancer.

ANGPTL3, Apo CIII, Leptin and Triglycerides Are Elevated in Metastatic Prostate Cancer.

Journal: Cancers
Published: March 12, 2026

Prognostic Significance of the Cytoplasmic Expression of UDP-glucuronosyltransferase 2B17 in Localized Prostate Cancer: Insights from the Canadian Prostate Cancer Biomarker Network and PROCURE Multi-institutional Cohorts.

Prognostic Significance of the Cytoplasmic Expression of UDP-glucuronosyltransferase 2B17 in Localized Prostate Cancer: Insights from the Canadian Prostate Cancer Biomarker Network and PROCURE Multi-institutional Cohorts.

Journal: European urology oncology
Published: May 16, 2025

External validation of the Memorial Sloan Kettering Cancer Center preoperative nomogram predicting lymph node invasion in a cohort of high-grade prostate cancer patients.

External validation of the Memorial Sloan Kettering Cancer Center preoperative nomogram predicting lymph node invasion in a cohort of high-grade prostate cancer patients.

Journal: The Prostate
Published: February 12, 2024

Regulatory and memory T lymphocytes infiltrating prostate tumors predict long term clinical outcomes.

Regulatory and memory T lymphocytes infiltrating prostate tumors predict long term clinical outcomes.

Journal: Frontiers in immunology
Published: January 18, 2024

The Germline and Somatic Origins of Prostate Cancer Heterogeneity.

The Germline and Somatic Origins of Prostate Cancer Heterogeneity.

Journal: Cancer discovery
Published: August 03, 2023

High infiltration of CD209+ dendritic cells and CD163+ macrophages in the peritumor area of prostate cancer is predictive of late adverse outcomes.

High infiltration of CD209+ dendritic cells and CD163+ macrophages in the peritumor area of prostate cancer is predictive of late adverse outcomes.

Journal: Frontiers in immunology
Published: April 13, 2023

The estrogen signaling pathway reprograms prostate cancer cell metabolism and supports proliferation and disease progression.

The estrogen signaling pathway reprograms prostate cancer cell metabolism and supports proliferation and disease progression.

Journal: The Journal of clinical investigation
Published: March 24, 2023

A phase IIb randomized placebo-controlled trial testing the effect of MAG-EPA long-chain omega-3 fatty acid dietary supplement on prostate cancer proliferation.

A phase IIb randomized placebo-controlled trial testing the effect of MAG-EPA long-chain omega-3 fatty acid dietary supplement on prostate cancer proliferation.

Journal: Communications medicine
Published: March 14, 2023

Leukocytic Infiltration of Intraductal Carcinoma of the Prostate: An Exploratory Study.

Leukocytic Infiltration of Intraductal Carcinoma of the Prostate: An Exploratory Study.

Journal: Cancers
Published: February 23, 2023

The landscape of N6-methyladenosine in localized primary prostate cancer.

The landscape of N6-methyladenosine in localized primary prostate cancer.

Journal: Nature genetics
Published: February 10, 2023

UGT2B28 accelerates prostate cancer progression through stabilization of the endocytic adaptor protein HIP1 regulating AR and EGFR pathways.

UGT2B28 accelerates prostate cancer progression through stabilization of the endocytic adaptor protein HIP1 regulating AR and EGFR pathways.

Journal: Cancer letters
Published: July 21, 2022
Showing 1-12 of 34

Last Updated: 09/26/2026